Page 12 - Flipbook

Impact of COVID-19 on Clinical Trials

• At PMCC, ~45% of trials were suspended

Highlighted need for Adjustments to continue beyond Potential benefits:
greater flexibility in: the pandemic:
• Increased patient

• Research infrastructure • Reducing unnecessary trial visits satisfaction

• Clinical trial design • Allow virtual consent • Decreased costs

• Virtual visits • Increased accrual
• Clinical trial conduct
• Electronic questionnaires • Inclusion of elderly
patients and patients from
• Electronic data entry
remote areas
• Enabling lab and imaging at
accredited local facilities

• Virtual study meetings and
monitoring site visits

1. Jiang DM, Berlin A, Moody L,. et al. Transitioning to a New Normal in the Post-COVID Era. Curr Oncol Rep. 2020;22:73.
12